Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction

J. P. Depta, P. A. Lenzini, D. E. Lanfear, T. Y. Wang, J. A. Spertus, R. G. Bach, S. Cresci

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction'. Together they form a unique fingerprint.

Medicine & Life Sciences